You are here

CT-388

‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day

Fierce Biotech

Wed, 09/11/24 - 11:15 pm

Carmot Therapeutics

Roche says it’ll move quickly with ‘differentiated’ obesity drugs

BioPharma Dive

Thu, 07/25/24 - 10:05 pm

Carmot Therapeutics

Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate

BioSpace

Thu, 05/16/24 - 11:40 am

clinical trials